Filter
2695
Filtered Results: 2695
Text search:
efficacy
of
medicines
Featured
Recommendations
286
New Publications
599
Language
Document type
No document type
1334
Guidelines
545
Studies & Reports
442
Manuals
150
Strategic & Response Plan
93
Training Material
46
Fact sheets
46
Situation Updates
14
Resource Platforms
9
Infographics
8
Brochures
5
Videos
2
Online Courses
1
Countries / Regions
Global
120
India
97
South Africa
68
Kenya
61
Uganda
52
Ethiopia
47
Western and Central Europe
44
Africa
43
Tanzania
42
Nigeria
37
Zambia
37
Latin America and the Carribbean
34
Liberia
32
Sierra Leone
31
Ghana
28
Rwanda
28
Nepal
27
Malawi
27
Bangladesh
25
Congo, Democratic Republic of
23
Russia
22
Philippines
19
Namibia
19
Zimbabwe
18
South–East Asia Region
18
Eastern Europe
18
Myanmar / Burma
18
Senegal
17
Ukraine
16
West and Central Africa
16
Brazil
16
Indonesia
16
Mozambique
15
Cameroon
14
Burkina Faso
14
East and Southern Africa
14
Lesotho
13
Cambodia
12
Guinea
11
Asia
11
Haiti
10
Germany
10
Eswatini/ Swaziland
10
Botswana
9
Pakistan
9
Benin
8
Laos
7
Vietnam
7
Syria
6
Peru
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
North America
6
Côte d’Ivoire / Ivory Coast
6
Sri Lanka
6
Sudan
6
Thailand
5
Afghanistan
5
USA
5
Mali
5
South Sudan
5
China
4
Western Pacific Region
4
France
4
United Kingdom
4
Lebanon
4
Angola
4
Chad
4
Madagascar
4
Chile
3
Niger
3
Venezuela
3
Jordan
3
Paraguay
3
Argentina
3
Georgia
3
Bhutan
3
Somalia
3
Colombia
2
Turkey
2
Iran
2
Albania
2
Morocco
2
Guinea-Bissau
2
Gabon
2
Tunisia
2
Spain
2
Yemen
2
Iraq
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Australia
1
Togo
1
Canada
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Burundi
1
Qatar
1
Italy
1
Dominican Republic
1
Saudi Arabia
1
Denmark
1
Mauritius
1
Belize
1
Costa Rica
1
Panama
1
Papua New Guinea
1
Nicaragua
1
Greece
1
Central African Republic
1
Honduras
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
868
Clinical Guidelines
328
Public Health
166
Women & Child Health
119
Key Resources
63
Capacity Building
41
Pharmacy & Technologies
35
Toolboxes
Mental Health
263
COVID-19
260
HIV
234
TB
174
AMR
151
NTDs
143
Pharmacy
123
Malaria
88
Ebola & Marburg
67
NCDs
67
Caregiver
61
Rapid Response
47
Disability
47
Planetary Health
39
Refugee
23
2.0 Rapid Response
18
Conflict
14
Global Health Education
14
Health Financing Toolbox
13
Cholera
11
Zika
9
Polio
8
Natural Hazards
6
Specific Hazards
4
Social Ethics
4
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensur...
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ...
As countries aim to progress towards the Sustainable Development Goals (SDGs) and achieving universal health coverage, health inequities driven by racial discrimination and intersecting factors remain pervasive. Inequities experienced by indigenous peoples as well as people of African descent, Roma ...
Ebola Response Roadmap
recommended
The World Health Organization is issuing a "roadmap" to guide and coordinate the international response to the outbreak of Ebola virus disease in West Africa.
The aim is to stop ongoing Ebola transmission worldwide within 6–9 months, while rapidly managing the consequences of any further interna...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Over the period 2015 to 2019, scaling up a package of selected nutrition-specific and nutrition sensitive interventions to cover 90 per cent of Sudan would:
- Reduce the under-five mortality rate to 49/1,000 live births
- Reduce the prevalence of stunting to 25 per cent
- Reduce the ...
- Reduce the under-five mortality rate to 49/1,000 live births
- Reduce the prevalence of stunting to 25 per cent
- Reduce the ...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
This revised trainer's guide contains a prototype training schedule for four days. Teaching and learning strategies are highly interactive, using participatory and experiential approach. Training outcomes include developing skills in assessment of clients for risk factors; conduct basic screening pr...
Hand hygiene is vital for safe health care delivery, yet practices at the point of care remain suboptimal worldwide. A comprehensive research agenda is therefore necessary to improve our understanding of factors influencing hand hygiene behaviour and to strengthen appropriate interventions. This age...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs) to improve adherence to medication for epilepsy in South Africa. They found that utilizing CHWs to i...
WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, as well as preventing and responding to pandemics. It is one of our most effective tools against COVID-19, and an undervalued tool more generally in infec...
Based on WHO South-East Asia Regional Strategy on Autism Spectrum Disorder
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
The collaborative framework for implementation of the “WHO South-East Asia Regional Strategy on Autism Spectrum Disorders” articulates to Member States: the nature of autism spectrum disorder and the issues faced by ...
